FindTrial
Sign In

Value of 18F-FDG PET/CT in in the diagnosis and differential diagnosis of pulmonary artery sarcoma

Value of 18F-FDG PET/CT in in the diagnosis and differential diagnosis of pulmonary artery sarcoma

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000039230
Enrollment
Unknown
Registered
2020-10-22
Start date
2020-11-01
Completion date
Unknown
Last updated
2021-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Artery Sarcoma

Interventions

Gold Standard:Biopsy pathology
Index test:PET/CT

Sponsors

China-Japan Friendship Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Pathological diagnosis of pulmonary artery sarcoma for the first time 2. With PET/CT imaging within 1 week before surgery

Exclusion criteria

Exclusion criteria: Those who have been diagnosed and received chemotherapy or immunotherapy

Design outcomes

Primary

MeasureTime frame
SUVmax;—

Countries

China

Contacts

Public ContactFu Liping

China-Japan Friendship Hospital

flp39@163.com+8610 84205396

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026